PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Stearic acid
اسید استئاریک، استئاریک اسید
1Nonproprietary names
- BPStearic Acid
- JPStearic Acid
- Ph. Eur.Stearic Acid
- USP–NFStearic Acid
2Synonyms and trade names
cetylacetic acid; Crodacid; Emersol; Hystrene; Industrene; octadecanoic acid; Pristerene; acidum stearicum; E570
3Chemical name and CAS Registry Number
Octadecanoic acid · [57-11-4]
UNII 4ELV7Z65AP · PubChem CID 5281
4Empirical formula and molecular weight
C18H36O2 · 284.48
5Functional category
Lubricant
Typical concentrations: 1–3% · Dosage forms: Solid, Semi-solid
6Applications in pharmaceutical formulation
Used in oral products mainly as a tablet and capsule lubricant, and also as a binder and as a matrix or coating material in sustained-release forms. In topical products it is an emulsifying and solubilising agent and stiffener; partly neutralised with an alkali or triethanolamine it forms the soap-based emulsifier of 'vanishing' creams. It is also a hardening agent in suppositories. Typical concentrations: tablet lubricant 1–3% w/w; ointments and creams 1–20% w/w.
7Description
A hard, white or faintly yellow, somewhat glossy crystalline solid, or a white to yellowish-white powder, with a slight odour and taste suggesting tallow. The pharmaceutical material is a mixture of stearic and palmitic acids; Ph. Eur. describes types 50, 70 and 95 according to their nominal stearic acid content.
8Typical properties
- Melting point
- about 54–69 °C depending on grade (pure stearic acid ≈ 69 °C)
- Acid value
- ≈ 194–212
- Iodine value
- not more than about 4
- Solubility
- freely soluble in chloroform and ether; soluble in ethanol (95%), hexane and propylene glycol; practically insoluble in water
9Stability and storage conditions
Stable; an antioxidant may be added. Store in a well-closed container in a cool, dry place.
10Incompatibilities
Incompatible with most metal hydroxides and with oxidising agents. It forms insoluble stearates with many metals, so ointment bases containing stearic acid may become dry or lumpy when compounded with zinc or calcium salts.
11Method of manufacture
Obtained by hydrolysis (fat splitting) of animal fats or of vegetable oils such as hydrogenated palm or cottonseed oil; the fatty acid mixture is hydrogenated and separated by distillation, pressing or crystallisation to give the required stearic acid content.
12Safety
Widely used in oral and topical products and in foods, and regarded as non-toxic and non-irritant. It is a normal component of dietary fat.
13Handling precautions
Observe normal precautions for the quantity handled. Eye protection and gloves are recommended, and a dust mask where dust is generated. It is combustible.
14Regulatory status
GRAS listed. Accepted in Europe as a food additive (E570). Included in the FDA Inactive Ingredient Database (oral capsules and tablets, sublingual tablets, topical and vaginal preparations) and in non-parenteral medicines licensed in Europe.
15Related substances
Calcium stearate; magnesium stearate; palmitic acid; zinc stearate; stearyl alcohol.
16Comments
As a tablet lubricant stearic acid is less efficient than magnesium stearate but is less likely to slow dissolution or interact with drugs that are sensitive to alkaline earth salts. Grades differ in stearic:palmitic ratio and in source (animal or vegetable), which affects melting behaviour and suitability for some markets.